Evidence map›Paper›PMID 32112907›Full record

ReviewCancer letters2020

Imaging of intratumoral heterogeneity in high-grade glioma.

Leland S Hu, Andrea Hawkins-Daarud, Lujia Wang, Jing Li, Kristin R Swanson

Open access · greenAbstract readReview
In one paragraph

Review in Cancer letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 4 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 4 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Metabolite ratiomics: Rapid diagnosis and classification of gliomas for intraoperative application during brain surgery.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Review
  9. Article
  10. Preoperative MRI Intratumoral Heterogeneity Radiomics for Microvascular Invasion and Recurrence-Free Survival in HCC.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Leland S HuDepartment of Radiology, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA. Electronic address: Hu.leland@mayo.edu.
Andrea Hawkins-DaarudMathematical NeuroOncology Lab, Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd, Support, Services Building Suite 2-700, Phoenix, AZ, 85054, USA. Electronic address: Hawkins-Daarud.Andrea@mayo.edu.
Lujia WangSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, 699 S Mill Ave, Tempe, AZ, 85281, USA. Electronic address: lwang230@asu.edu.
Jing LiSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, 699 S Mill Ave, Tempe, AZ, 85281, USA. Electronic address: jing.li.8@asu.edu.
Kristin R SwansonMathematical NeuroOncology Lab, Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd, Support, Services Building Suite 2-700, Phoenix, AZ, 85054, USA. Electronic address: Swanson.Kristin@mayo.edu.
Decision Systems (United States) · USMayo Clinic in Arizona · USWinnMed · US

Funding

Quantifying Multiscale Competitive Landscapes of Clonal Diversity in GlioblastomaU01CA220378 · NCI · MAYO CLINIC ARIZONA · PI HU, LELAND, SWANSON, KRISTIN R · 2017 to 2021
$4.3M
Multi-site Validation and Application of a Consensus DSC MRI ProtocolR01CA221938 · NCI · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI BOXERMAN, JERROLD L, HU, LELAND · 2018 to 2020
$738k
MRI-based mapping of regional genomic diversity in GlioblastomaR21NS082609 · NINDS · MAYO CLINIC ARIZONA · PI HU, LELAND · 2013 to 2014
$525k
NCI NIH HHS R01 CA221938NCI NIH HHS U01 CA220378NINDS NIH HHS R21 NS082609
6 · The paper itself

Abstract

High-grade glioma (HGG), and particularly Glioblastoma (GBM), can exhibit pronounced intratumoral heterogeneity that confounds clinical diagnosis and management. While conventional contrast-enhanced MRI lacks the capability to resolve this heterogeneity, advanced MRI techniques and PET imaging offer a spectrum of physiologic and biophysical image features to improve the specificity of imaging diagnoses. Published studies have shown how integrating these advanced techniques can help better define histologically distinct targets for surgical and radiation treatment planning, and help evaluate the regional heterogeneity of tumor recurrence and response assessment following standard adjuvant therapy. Application of texture analysis and machine learning (ML) algorithms has also enabled the emerging field of radiogenomics, which can spatially resolve the regional and genetically distinct subpopulations that coexist within a single GBM tumor. This review focuses on the latest advances in neuro-oncologic imaging and their clinical applications for the assessment of intratumoral heterogeneity.

Indexed as

AlgorithmsBrain NeoplasmsContrast MediaGliomaHumansMachine LearningMagnetic Resonance ImagingNeoplasm Recurrence, LocalPositron-Emission TomographyTherapy, Computer-AssistedContrast MediaAdvancedGlioblastomaGliomaHeterogeneityHistologicImagingIntratumoralMRIRadiogenomics

Identifiers

PMID32112907
PMCPMC7108976
OpenAlexW3008041853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.